Pharma News - Research & Development News & Articles

681 GSK and Biological E. announce joint venture to develop combination vaccine for India and other developing countries Full Text GlaxoSmithKline, January 29, 2013

682 Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl) Takeda Pharmaceuticals U.S.A., January 28, 2013

683 Pfizer Receives FDA Approval For The Use Of Prevnar 13 In Vaccine-Naive Children And Adolescents Aged 6 Years Through 17 Years For The Prevention Of Invasive Pneumococcal Disease Full Text Pfizer, January 28, 2013

684 Amgen Announces Results From Phase 3 PAVES Study Evaluating Neulasta (pegfilgrastim) In Patients With Colorectal Cancer Full Text Amgen, January 28, 2013

685 FDA Approves OXYTROL FOR WOMEN, the First Over-the-Counter Treatment for Overactive Bladder in Women Full Text Merck, January 28, 2013

686 Pfizer Announces Top-Line Efficacy Results From A Phase 4 Study Of PRISTIQ (desvenlafaxine) For The Treatment Of Major Depressive Disorder (MDD) In Adults Full Text Pfizer, January 25, 2013

687 FDA approves new use of Avastin plus chemotherapy for people with metastatic colorectal cancer Full Text Roche, January 25, 2013

688 Study Shows Higher Dose Of Toviaz (fesoterodine fumarate) Offers Greater Efficacy In Reducing Urge Urinary Incontinence In Patients With Overactive Bladder Full Text Pfizer, January 25, 2013

689 Gilead Initiates Phase 3 Clinical Program for Tenofovir Alafenamide, a Novel Low-Dose Prodrug for the Treatment of HIV Full Text Gilead, January 25, 2013

690 Cellmid Records Positive Data in Midkine Antibody Study in Kidney Disease B3C newswire, January 25, 2013

691 New England Journal of Medicine Publishes Pivotal Trial Data for OMONTYS (peginesatide) Injection for Treatment of Anemia in Adult Chronic Kidney Disease Patients on Hemodialysis Takeda Pharmaceuticals U.S.A., January 24, 2013

692 FDA Approves New Use Of Avastin Plus Chemotherapy For People With Metastatic Colorectal Cancer Full Text Genentech, January 24, 2013

693 Teva Reports Top-Line Results from Second Phase III Study of Armodafinil (NUVIGIL) in Patients with Major Depression Associated with Bipolar 1 Disorder Full Text Teva Pharmaceutical Industries, January 24, 2013

694 Sanofi and Regeneron Announce New ZALTRAP (ziv-aflibercept) Analyses in Previously Treated Metastatic Colorectal Cancer To Be Presented at Upcoming ASCO GI Symposium Full Text Sanofi, January 23, 2013

695 Par Pharmaceutical Begins Shipment of Generic Lamictal XR Par Pharmaceutical, January 23, 2013

696 Teva and Xenon Announce Tevas World Wide License of Xenons Pain Drug XEN402 Full Text Teva Pharmaceutical Industries, January 23, 2013

697 Astellas’ New Headquarters for the Americas Awarded LEED Gold Certification Full Text Astellas, January 23, 2013

698 Bayer: Committed to help raise agricultural productivity in Africa Full Text BayNews International, January 23, 2013

699 AAIPharma Expands Laboratory Service Offerings and Capabilities in its Technology Center Full Text AAIPharma, January 23, 2013

700 GKAs for diabetes therapy: why no clinically useful drug after two decades of trying? Trends in Pharmacological Sciences, January 23, 2013

1 FDA Commissioner Claims Resistance to Compounding Pharmacy Inspections BioPharm International, April 15, 2013    Free full text

2 New Abbott Test Can Help Doctors Detect the Presence of Two Important Health Issues Abbott, March 29, 2013    Free full text

3 Dr. Reddys to Relocate North America HQ BioPharm International, April 11, 2013    Free full text

4 Drug Discovery Initiative Launched in Europe BioPharm International, February 12, 2013    Free full text

5 Sarepta Therapeutics Announces Eteplirsen Demonstrates Sustained Benefit on Walking Test Through 74 Weeks in Phase IIb Study in Duchenne Muscular Dystrophy Sarepta Therapeutics, April 10, 2013    Free full text

6 CHOP Collaborates With Pfizers Centers For Therapeutic Innovation To Speed Pediatric Research & Development Pfizer, April 4, 2013    Free full text

7 FDA launches partnership to protect against counterfeit anti-malarial medicines with FDA-developed handheld detection tool FDA Press Announcements, April 26, 2013    Free full text

8 New research sheds light on NSAID risks American Pharmacists Association News, April 4, 2013    Free full text

9 Mallinckrodt International Finance S.A. Announces Private Offering of Senior Unsecured Notes Covidien, April 10, 2013    Free full text

10 Doctors Agree Small Lifestyle Changes Can Improve Outcomes of Patients with Type 2 Diabetes, National Survey Finds Janssen, March 15, 2013    Free full text

11 ARIAD Presents New Preclinical Data Showing Ponatinib Overcomes Resistant Mutations in KIT, an Oncogenic Driver of Gastrointestinal Stromal Tumors ARIAD Pharmaceuticals, April 10, 2013    Free full text

12 Achieving More Effective and Efficient GMP Auditing BioPharm International, April 3, 2013    Free full text

13 FDA Drug Safety Communication: Azithromycin (Zithromax or Zmax) and the risk of potentially fatal heart rhythms FDA What's New: Drugs, March 15, 2013    Free full text

14 The Future of ACOs Remains Cloudy The Hospitalist, April 11, 2013    Free full text

15 Emerging Outsourcing Trends in 2013 BioPharm International, April 3, 2013    Free full text

16 Medivation and astellas provide update on prevail Astellas, April 5, 2013    Free full text

17 Catalent Biologics Expands Into ADCs BioPharm International, April 12, 2013    Free full text

18 Revolutionary Autoinjector Pushes the Limits of High Viscosity Drug Delivery B3C newswire, April 19, 2013    Free full text

19 AstraZeneca to Cut 1600 Positions in R&D Reorganization BioPharm International, March 22, 2013    Free full text

20 Valeant Pharmaceuticals Announces Private Exchange Offer Valeant Pharmaceuticals International, April 1, 2013    Free full text